Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;12(4):401-3.
doi: 10.4142/jvs.2011.12.4.401.

Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate

Affiliations

Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate

Min-Kyoung Shin et al. J Vet Sci. 2011 Dec.

Abstract

Corn, one of the most important forage crops worldwide, has proven to be a useful expression vehicle due to the availability of established transformation procedures for this well-studied plant. The exotoxin Apx, a major virulence factor, is recognized as a common antigen of Actinobacillus (A.) pleuropneumoniae, the causative agent of porcine pleuropneumonia. In this study, a cholera toxin B (CTB)-ApxIIA#5 fusion protein and full-size ApxIIA expressed in corn seed, as a subunit vaccine candidate, were observed to induce Apx-specific immune responses in mice. These results suggest that transgenic corn-derived ApxIIA and CTB-ApxIIA#5 proteins are potential vaccine candidates against A. pleuropneumoniae infection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ApxII-specific IgG (A) and IgA (B) levels 2 weeks after final boosting (**p < 0.01). CTB: cholera toxin B.
Fig. 2
Fig. 2
ApxII-specific memory B cells producing IgG (A) and IgA (B) in mice immunized with corn-derived ApxIIA (█: untreated control, ▒: ApxIIA, □: lipopolysaccharides; *p < 0.05, **p < 0.01).
Fig. 3
Fig. 3
Secretion of interferon-γ (A) and nitric oxide (B) from murine splenocytes stimulated with ApxIIA and ConA, or the untreated control (█: administration of cholera toxin B-ApxIIA#5, □: administration of full ApxIIA; *p < 0.05, **p < 0.01).

Similar articles

Cited by

References

    1. Arakawa T, Chong DKX, Merritt JL, Langridge WHR. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 1997;6:403–413. - PubMed
    1. Bossé JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Langford PR. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 2002;4:225–235. - PubMed
    1. Floss DM, Falkenburg D, Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 2007;16:315–332. - PMC - PubMed
    1. Frey J, Nicolet J. Immunological properties of Actinobacillus pleuropneumoniae hemolysin I. Vet Microbiol. 1991;28:61–73. - PubMed
    1. Kim HA, Yoo HS, Yang MS, Kwon SY, Kim JS, Choi PS. The development of transgenic maize expressing Actinobacillus pleuropneumoniae ApxIIA gene using Agrobacterium. J Plant Biotechnol. 2010;37:313–318.

Publication types